Oruka Therapeutics (ORKA) Cash from Investing Activities (2010 - 2026)
Oruka Therapeutics' quarterly Cash from Investing Activities came in at -$14.4 million in Q1 2026, down 133.68% year-on-year from $42.9 million in Q1 2025, and up 34.44% quarter-over-quarter from -$22.0 million in Q4 2025.
Oruka Therapeutics has reported Cash from Investing Activities for 15 years, with the latest figure at -$14.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 133.68% year-over-year to -$14.4 million; the trailing twelve-month figure through Mar 2026 stood at -$154.0 million (up 46.37% YoY), and the FY2025 full-year result was -$96.7 million, up 70.69% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$14.4 million, up from -$22.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $42.9 million in Q1 2025, with the low at -$330.0 million in Q4 2024.
- Average Cash from Investing Activities over 4 years is -$55.2 million, with a median of -$7.3 million recorded in 2024.
- Peak annual rise in Cash from Investing Activities reached 93.33% in 2025, while the deepest fall reached 71507.6% in 2025.
- Tracing ORKA's Cash from Investing Activities over 4 years: stood at -$2000.0 in 2022, then plunged by 16497700.0% to -$330.0 million in 2024, then jumped by 93.33% to -$22.0 million in 2025, then jumped by 34.44% to -$14.4 million in 2026.
- The last three Cash from Investing Activities figures came in at -$14.4 million (Q1 2026), -$22.0 million (Q4 2025), and -$122.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | -14.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.44 Mn |
| Mar 31, 2026 | -14.44 Mn |
| Dec 31, 2025 | -22.02 Mn |
| Dec 31, 2025 | -22.02 Mn |
| Sep 30, 2025 | -122.45 Mn |
| Sep 30, 2025 | -122.45 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Mar 31, 2025 | 42.87 Mn |
| Mar 31, 2025 | 42.87 Mn |
| Dec 31, 2024 | -329.96 Mn |
| Dec 31, 2024 | -329.96 Mn |
| Sep 30, 2024 | -171,000.00 |
| Sep 30, 2024 | -171,000.00 |
| Mar 31, 2022 | -2,000.00 |
| Mar 31, 2022 | -2,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | -14,000.00 |
| Sep 30, 2021 | -14,000.00 |
| Jun 30, 2021 | -16,000.00 |
| Jun 30, 2021 | -16,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Dec 31, 2020 | -13,000.00 |
| Dec 31, 2020 | -13,000.00 |
| Jun 30, 2020 | -3,000.00 |
| Jun 30, 2020 | -3,000.00 |
| Mar 31, 2020 | -3,000.00 |
| Mar 31, 2020 | -3,000.00 |
| Dec 31, 2019 | -2,000.00 |
| Dec 31, 2019 | -2,000.00 |
| Sep 30, 2018 | -3,000.00 |
| Sep 30, 2018 | -3,000.00 |
| Mar 31, 2018 | 3.05 Mn |
| Mar 31, 2018 | 3.05 Mn |
| Dec 31, 2017 | 4.75 Mn |
| Dec 31, 2017 | 4.75 Mn |
| Sep 30, 2017 | -932,000.00 |
| Sep 30, 2017 | -932,000.00 |
| Jun 30, 2017 | 6.10 Mn |
| Jun 30, 2017 | 6.10 Mn |
| Mar 31, 2017 | 3.01 Mn |
| Mar 31, 2017 | 3.01 Mn |
| Dec 31, 2016 | 3.15 Mn |
| Dec 31, 2016 | 3.15 Mn |
| Sep 30, 2016 | -2.55 Mn |
| Sep 30, 2016 | -2.55 Mn |
| Jun 30, 2016 | -11.81 Mn |
| Jun 30, 2016 | -11.81 Mn |
| Mar 31, 2016 | -5.20 Mn |
| Mar 31, 2016 | -5.20 Mn |
| Dec 31, 2015 | -2,000.00 |
| Dec 31, 2015 | -2,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Jun 30, 2015 | -5,000.00 |
| Jun 30, 2015 | -5,000.00 |
| Mar 31, 2015 | -2,000.00 |
| Mar 31, 2015 | -2,000.00 |
| Dec 31, 2014 | -14,000.00 |
| Dec 31, 2014 | -14,000.00 |
| Dec 31, 2013 | -4,000.00 |
| Dec 31, 2013 | -4,000.00 |
| Sep 30, 2013 | -11,000.00 |
| Sep 30, 2013 | -11,000.00 |
| Jun 30, 2013 | -8,000.00 |
| Jun 30, 2013 | -8,000.00 |
| Mar 31, 2013 | -9,000.00 |
| Mar 31, 2013 | -9,000.00 |
| Dec 31, 2011 | 5,000.00 |
| Dec 31, 2011 | 5,000.00 |
| Sep 30, 2011 | 1,000.00 |
| Sep 30, 2011 | 1,000.00 |
| Dec 31, 2010 | 261,000.00 |
| Dec 31, 2010 | 261,000.00 |